Personal Products

Medifast, Inc. (NYSE: MED) shares continue their sharp decline today, down some 23% after announcing the company would be restating its year-end financial statements. Straight from the press release: The Company requires additional time to complete its year-end financial statements. The delay in...

Piper Jaffray has a Neutral rating and a $4 price target on shares of Physicians Formula (NASDAQ: FACE). In a note to investors, Piper Jaffray writes, "Physicians Formula reported better-than-expected net sales and revenue in FQ4despite posting a wider-than-expected loss per share. It appears...

Below are the top large-cap personal product stocks on the NYSE and the NASDAQ in terms of profit margin. The trailing-twelve-month profit margin at Colgate-Palmolive Company (NYSE: CL) is 14.15%. CL's ROE for the same period is 76.16%. The trailing-twelve-month profit margin at Procter &...

 ( click to enlarge ) Corning Incorporated (NYSE:GLW) tried to break down today but buyers came in to support and the stock closed again above the $22 level. On daily chart we can see a pull back with low volume indicating a consolidation phase after some bullish momentum. The bias is neutral...

Mannatech, Incorporated (NASDAQ: MTEX), a leading developer and provider of nutritional supplements and skin care products based on Real Food Technology® solutions, today reported a net loss of $2.7 million or $0.10 cents per diluted share for the fourth quarter ending December 31, 2010, compared...

Herbalife (NYSE: HLF) today announced that it has entered into a new $700 million senior secured revolving credit facility. The new five year facility matures on March 9, 2016. This new facility was arranged by Bank of America Merrill Lynch and JP Morgan Securities LLC as joint lead arrangers and...

Moody's cut the outlook on Avon Products's (NYSE: AVP) on the company to negative from stable, but reaffirmed its A2 senior unsecured long term rating. "Persistent weakness in major developed markets, execution-related problems in key developing markets, high spending levels on advertising and...

Piper Jaffray raised its Inter Parfums (NASDAQ: IPAR) price target from $18 to $21 in a research report published today. Piper Jaffray has previously given Inter Parfums a Neutral rating. In the report, Piper Jaffray states, "The company reported EPS of $0.20, which was ahead of our estimate of $0...

Piper Jaffray has raised the price target on Inter Parfums (NASDAQ: IPAR) from $18 to $21 and maintains its Neutral rating.

Inter Parfums, Inc. (NASDAQ: IPAR) today reported results for the fourth quarter and year ended December 31, 2010. Net sales declined slightly to $112.4 million from $112.9 million; at comparable foreign currency exchange rates, net sales rose 6% for the period; Basic and diluted earnings per...

American Oriental Bioengineering, Inc. (NYSE: AOB), today announced that it plans to release fourth quarter and full year 2010 financial results on Monday, March 14, 2011, after the market closes. The Company will hold a conference call at 8:00 am ET on Tuesday, March 15, 2011, to discuss its...

On CNBC's Mad Money, Jim Cramer said during the Lightning Round that Medifast (NYSE: MED) has “no growth.” He added, “I suggest you look into Weight Watcher's (NYSE: WTW) which has great growth and is shareholder friendly." Cramer likes PPL Corp (NYSE: PPL), adding that the stock is a “super duper...

Below are the top small-cap personal products stocks on the NYSE and the NASDAQ in terms of earnings estimate for the next year. The earnings estimate for Blyth Inc (NYSE: BTH) for the next year ending January, 2012 is $2.90 per share. BTH's PEG ratio is 1.20. Nu Skin Enterprises Inc (NYSE: NUS) is...

Shares of Medifast, Inc. (NYSE: MED) are lower on the session by 1.64%, currently trading at $21.57. The stock has been moving largely lower over the past six months and is currently trading below the 50-day and 200-day moving averages. Options traders are buying calls on the name today. A short...

IndexUninverse had a post about a new line of ETFs coming from a company called FocusShares that will include some broad index funds along with some sector funds and because the company is owned by Scottrade the funds will trade commission-free for Scottrade customers. Most of the proposed funds...